Some of the stories that caught my attention:

• New recommendations have been published by ASCO on the use of biomarkers to guide in the treatment for metastatic breast cancer.
• Researchers at Cedars-Sinai have discovered a genetic biomarker responsible for the progression of many breast and prostate cancers. The findings could help to contribute to better identify patients who respond to certain types of chemotherapy drugs. Read more about the findings in the journal Scientific Reports.
• Scientists at MD Anderson have found a link between a protein called CSN6 and patients with colorectal cancer. The results of the study have been published in the journal Cancer Cell.
• According to a recent study published in the Journal of Investigative Dermatology, soldiers returning home from Iraq and Afghanistan have an increased risk of developing skin cancer.
• The Obama administration announced that Medicare will start paying for the cancer drug Blincyto produced by Amgen Inc. It is currently used to treat a rare form of acute lymphoblastic leukemia.